AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

COGNITION THERAPEUTICS INC Director's Dealing 2021

Oct 8, 2021

34027_dirs_2021-10-07_44b1470f-0b7e-4e29-8a59-85c93a2fe5ca.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: COGNITION THERAPEUTICS INC (CGTX)
CIK: 0001455365
Period of Report: 2021-10-07

Reporting Person: Wallace Peggy (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Ownership
Stock Option (right to buy)	$1.75	2031-02-23	Common Stock (3864)	Direct
Stock Option (right to buy)	$0.87	2027-04-28	Common Stock (7729)	Direct
Stock Option (right to buy)	$1.07	2030-02-27	Common Stock (3864)	Direct
Stock Option (right to buy)	$1.07	2030-02-27	Common Stock (7729)	Direct

Footnotes

F1: The option vests in four (4) equal annual installments beginning on the first anniversary of the option's grant date. The option was granted on February 23, 2021.

F2: The option is fully vested.

F3: The option vests in four (4) equal annual installments beginning on the first anniversary of the option's grant date. The option was granted on February 27, 2020.